Filing Details
- Accession Number:
- 0001415889-24-013755
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-20 16:33:21
- Reporting Period:
- 2024-05-16
- Accepted Time:
- 2024-05-20 16:33:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1923840 | Third Harmonic Bio Inc. | THRD | Pharmaceutical Preparations (2834) | 834553503 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2022925 | Jennifer Dittman | C/O Third Harmonic Bio, Inc. 1700 Montgomery Street, Suite 210 San Francisco CA 94111 | Chief Development Oper Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-16 | 16,666 | $4.30 | 16,666 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-05-16 | 6,912 | $4.20 | 23,578 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-05-16 | 23,578 | $14.04 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2024-05-16 | 100,000 | $0.00 | 100,000 | $14.23 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-05-16 | 16,666 | $0.00 | 16,666 | $4.30 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-05-16 | 6,912 | $0.00 | 6,912 | $4.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,000 | 2034-05-15 | No | 4 | A | Direct | |
| 33,334 | 2032-12-18 | No | 4 | M | Direct | |
| 16,788 | 2033-03-05 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.0778 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- 25% of the total shares vest on May 16, 2025, and thereafter 2.08333% of the total shares underlying the award shall vest in equal monthly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- 25% of the total shares vest on December 19, 2023, and thereafter 2.08333% of the total shares underlying the award shall vest in equal monthly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
Billionaire Hedge Funds
